Francis Chou - Chou Associates Management 13F Activity & Position Changes (Q1 2017)
As of Mar 31, 2017, the Chou Associates Management portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q1 2017, the filing reported:
New Buys - Teva Pharmaceutical Industries
Increases - SandRidge Energy, Inc.
Reductions - Nokia Corporation Sponsored
Complete Exits - Astrazeneca PLC
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.